168 related articles for article (PubMed ID: 8510231)
41. DEK, an autoantigen involved in a chromosomal translocation in acute myelogenous leukemia, binds to the HIV-2 enhancer.
Fu GK; Grosveld G; Markovitz DM
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1811-5. PubMed ID: 9050861
[TBL] [Abstract][Full Text] [Related]
42. Transcription factor AP-2 regulates human immunodeficiency virus type 1 gene expression.
Perkins ND; Agranoff AB; Duckett CS; Nabel GJ
J Virol; 1994 Oct; 68(10):6820-3. PubMed ID: 8084021
[TBL] [Abstract][Full Text] [Related]
43. ATF and Jun transcription factors, acting through an Ets/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic Mono Mac 6 cells.
Boehlk S; Fessele S; Mojaat A; Miyamoto NG; Werner T; Nelson EL; Schlöndorff D; Nelson PJ
Eur J Immunol; 2000 Apr; 30(4):1102-12. PubMed ID: 10760799
[TBL] [Abstract][Full Text] [Related]
44. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
45. Human immunodeficiency virus type-2 gene expression: two enhancers and their activation by T-cell activators.
Arya SK
New Biol; 1990 Jan; 2(1):57-65. PubMed ID: 1981844
[TBL] [Abstract][Full Text] [Related]
46. Functional interaction of nuclear factors EF-C, HNF-4, and RXR alpha with hepatitis B virus enhancer I.
Garcia AD; Ostapchuk P; Hearing P
J Virol; 1993 Jul; 67(7):3940-50. PubMed ID: 8389913
[TBL] [Abstract][Full Text] [Related]
47. Repeated B motifs in the human immunodeficiency virus type I long terminal repeat enhancer region do not exhibit cooperative factor binding.
Gaynor RB; Kuwabara MD; Wu FK; Garcia JA; Harrich D; Briskin M; Wall R; Sigman DS
Proc Natl Acad Sci U S A; 1988 Dec; 85(24):9406-10. PubMed ID: 3200827
[TBL] [Abstract][Full Text] [Related]
48. Regulation of human immunodeficiency virus enhancer function by PRDII-BF1 and c-rel gene products.
Muchardt C; Seeler JS; Nirula A; Shurland DL; Gaynor RB
J Virol; 1992 Jan; 66(1):244-50. PubMed ID: 1727488
[TBL] [Abstract][Full Text] [Related]
49. A human cytomegalovirus early promoter with upstream negative and positive cis-acting elements: IE2 negates the effect of the negative element, and NF-Y binds to the positive element.
Huang L; Malone CL; Stinski MF
J Virol; 1994 Apr; 68(4):2108-17. PubMed ID: 8138995
[TBL] [Abstract][Full Text] [Related]
50. Alterations in binding characteristics of the human immunodeficiency virus enhancer factor.
Wu F; Garcia J; Mitsuyasu R; Gaynor R
J Virol; 1988 Jan; 62(1):218-25. PubMed ID: 3257103
[TBL] [Abstract][Full Text] [Related]
51. Negative regulation of human immunodeficiency virus type 1 expression in monocytes: role of the 65-kDa plus 50-kDa NF-kappa B dimer.
Raziuddin ; Mikovits JA; Calvert I; Ghosh S; Kung HF; Ruscetti FW
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9426-30. PubMed ID: 1946356
[TBL] [Abstract][Full Text] [Related]
52. PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.
Eisenbeis CF; Singh H; Storb U
Mol Cell Biol; 1993 Oct; 13(10):6452-61. PubMed ID: 8413244
[TBL] [Abstract][Full Text] [Related]
53. Synergistic activation of simian immunodeficiency virus and human immunodeficiency virus type 1 transcription by retinoic acid and phorbol ester through an NF-kappa B-independent mechanism.
Maciaszek JW; Talmage DA; Viglianti GA
J Virol; 1994 Oct; 68(10):6598-604. PubMed ID: 8083995
[TBL] [Abstract][Full Text] [Related]
54. Regulation of avian leukosis virus long terminal repeat-enhanced transcription by C/EBP-Rel interactions.
Bowers WJ; Baglia LA; Ruddel A
J Virol; 1996 May; 70(5):3051-9. PubMed ID: 8627783
[TBL] [Abstract][Full Text] [Related]
55. Importance of low affinity Elf-1 sites in the regulation of lymphoid-specific inducible gene expression.
John S; Marais R; Child R; Light Y; Leonard WJ
J Exp Med; 1996 Mar; 183(3):743-50. PubMed ID: 8642278
[TBL] [Abstract][Full Text] [Related]
56. Identification of a novel constitutive enhancer element and an associated binding protein: implications for human papillomavirus type 11 enhancer regulation.
Chin MT; Broker TR; Chow LT
J Virol; 1989 Jul; 63(7):2967-76. PubMed ID: 2542607
[TBL] [Abstract][Full Text] [Related]
57. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
58. Developmental regulation of the Drosophila Tropomyosin I (TmI) gene is controlled by a muscle activator enhancer region that contains multiple cis-elements and binding sites for multiple proteins.
Lin SC; Storti RV
Dev Genet; 1997; 20(4):297-306. PubMed ID: 9254904
[TBL] [Abstract][Full Text] [Related]
59. Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.
Pöhlmann S; Flöss S; Ilyinskii PO; Stamminger T; Kirchhoff F
J Virol; 1998 Jul; 72(7):5589-98. PubMed ID: 9621017
[TBL] [Abstract][Full Text] [Related]
60. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
